Assisted reproduction technology and long-term cardiometabolic health in the offspring.

Autor: Ma RCW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong.; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong., Ng NYH; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong., Cheung LP; Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories Hong Kong.
Jazyk: angličtina
Zdroj: PLoS medicine [PLoS Med] 2021 Sep 07; Vol. 18 (9), pp. e1003724. Date of Electronic Publication: 2021 Sep 07 (Print Publication: 2021).
DOI: 10.1371/journal.pmed.1003724
Abstrakt: Ronald Ma and co-authors discuss Emma Norrman and colleagues' accompanying research study on the health of children born with assisted reproductive technology.
Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: RCWM is member of the editorial board of PLOS Medicine. RCWM has received research grants for clinical trials from AstraZeneca, Bayer, MSD, Novo Nordisk, Sanofi, Tricida Inc. and honoraria for consultancy or lectures from AstraZeneca, and Boehringer Ingelheim, all used to support diabetes research at the Chinese University of Hong Kong.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje